Middle East & Africa Catastrophic Antiphospholipid Syndrome Market Size & Outlook
The catastrophic antiphospholipid syndrome market in Middle East & Africa is expected to reach a projected revenue of US$ 293.9 million by 2030. A compound annual growth rate of 9.5% is expected of Middle East & Africa catastrophic antiphospholipid syndrome market from 2024 to 2030.
Revenue, 2023 (US$M)
$155.9
Forecast, 2030 (US$M)
$293.9
CAGR, 2024 - 2030
9.5%
Report Coverage
Middle East & Africa
Related Markets
MEA catastrophic antiphospholipid syndrome market highlights
- The MEA catastrophic antiphospholipid syndrome market generated a revenue of USD 155.9 million in 2023.
- The market is expected to grow at a CAGR of 9.5% from 2024 to 2030.
- In terms of segment, anticoagulants was the largest revenue generating treatment in 2023.
- Anticoagulants is the most lucrative treatment segment registering the fastest growth during the forecast period.
MEA data book summary
| Market revenue in 2023 | USD 155.9 million |
| Market revenue in 2030 | USD 293.9 million |
| Growth rate | 9.5% (CAGR from 2023 to 2030) |
| Largest segment | Anticoagulants |
| Fastest growing segment | Anticoagulants |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Anticoagulants |
| Key market players worldwide | Pfizer Inc, Abbott Laboratories, Bristol-Myers Squibb Co, Eli Lilly and Co, Boehringer Ingelheim, Novartis AG ADR, Merck KGaA, AbbVie Inc, Roche Holding AG, Johnson & Johnson |
Other key industry trends
- In terms of revenue, MEA region accounted for 3.5% of the global catastrophic antiphospholipid syndrome market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,220.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Catastrophic Antiphospholipid Syndrome Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Eli Lilly and Co | View profile | 43000 | Lilly Corporate Center, Indianapolis, IN, United States, 46285 | https://www.lilly.com |
| Boehringer Ingelheim | View profile | 10001+ | Ingelheim Am Rhein, Rheinland-Pfalz, Germany, Europe | https://www.boehringer-ingelheim.com/ |
| Bristol-Myers Squibb Co | View profile | 34100 | Route 206 and Province Line Road, Princeton, New Jersey, NJ, United States, 08543 | https://www.bms.com |
| Roche Holding AG | View profile | 103605 | Grenzacherstrasse 124, Basel, Switzerland, 4070 | https://www.roche.com |
| Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
| AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
| Abbott Laboratories | View profile | 114000 | 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 | https://www.abbottinvestor.com |
| Merck KGaA | View profile | 62345 | Frankfurter Strasse 250, Darmstadt, HE, Germany, 64293 | https://www.emdgroup.com |
| Novartis AG ADR | View profile | 76057 | Lichtstrasse 35, Basel, Switzerland, 4056 | https://www.novartis.com |
| Johnson & Johnson | View profile | 134400 | One Johnson and Johnson Plaza, New Brunswick, NJ, United States, 08933 | https://www.jnj.com |
Related industry reports
Related statistics
No records
No related statistics found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
